OVID Ovid Therapeutics Inc.: institutional ownership and insider trading
142 funds reported holding $435M of Ovid Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $85.7M, with 45 new positions and 17 funds selling out; over the last 12 months insiders bought $0 and sold $29.3K on the open market.
Famous investors holding OVID
- Two Sigma (Two Sigma Investments): $2.24M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $284K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $123K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $99.2K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $86.9K, 0.0% of the portfolio
Largest institutional holders of OVID
- Jupiter Topco LLC — $55.9M
- EVENTIDE ASSET MANAGEMENT, LLC — $31.8M
- BlackRock, Inc. (BLK) — $29.1M
- RA CAPITAL MANAGEMENT, L.P. — $28.2M
- Affinity Asset Advisors, LLC — $27.3M
- JANUS HENDERSON GROUP PLC (JHG) — $23.7M
- STATE STREET CORP (STT, STT-PG) — $21.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $20.9M
- ADAR1 Capital Management, LLC — $20.0M
- BALYASNY ASSET MANAGEMENT L.P. — $18.1M
Recent OVID insider trades
- Feb 23, 2026: Rona Jeffrey A sold 8,541 shares ($12.4K)
- Feb 23, 2026: Alexander Margaret A. sold 11,656 shares ($16.9K)
- Feb 26, 2025: Alexander Margaret A. sold 5,279 shares ($2.96K)
- Feb 26, 2025: Rona Jeffrey A sold 3,902 shares ($2.19K)
5%+ owners
- RA Capital Management, L.P.: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
- Sirenia Capital Management LP: 9.9% (Schedule 13G, filed May 15, 2026)
- Affinity Asset Advisors, LLC: 7.9% (Schedule 13G/A, filed Aug 13, 2026)
- Eventide Asset Management, LLC: 6.3% (Schedule 13G/A, filed Aug 14, 2026)
- BlackRock, Inc.: 5.8% (Schedule 13G, filed Jul 29, 2026)
- ADAR1 Capital Management, LLC: 5.1% (Schedule 13G/A, filed Aug 14, 2026)